Estiva 600mg Tablet contains Efavirenz, a non-nucleoside reverse transcriptase inhibitor (NNRTI), used in the treatment of HIV-1 infection. Efavirenz works by inhibiting the reverse transcriptase enzyme, reducing the replication of the virus in the bloodstream and supporting immune health. Estiva is typically prescribed as part of combination antiretroviral therapy (ART) to control HIV progression effectively.
Uses:
- Manages and treats HIV-1 infection
- Reduces viral load and slows HIV progression in the body
Side Effects:
- Common side effects include dizziness, headache, insomnia, and nausea.
- Rare side effects may include mood changes, liver complications, or skin rashes. Seek medical advice for any unusual symptoms.
Key Features:
- Contains Efavirenz, an effective NNRTI for HIV control
- Lowers viral load, supporting immune system health
- Part of a comprehensive ART for HIV management
References:
- Efavirenz – Mediline Plus. Available from: https://medlineplus.gov/druginfo/meds/a699004.html
- Efavirenz 600 mg Tablets – EMC. Available from:https://www.ncbi.nlm.nih.gov/books/NBK542316/

Reviews
There are no reviews yet